EcoDrugPlus

Cyclin Dependent Kinase 2

Ensembl ID : ENSPREG00000014294
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSPREG00000014735
Gene Symbol: CDK4
3 Cross references
237 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSPREG00000008002
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSPREG00000002969
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSPREG00000002650
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSPREG00000007624
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPREG00000022009
Gene Symbol: CYSLTR1
3 Cross references
172 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSPREG00000002451
Gene Symbol: LOC103464914
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSPREG00000003123
Gene Symbol: LOC103482193
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSPREG00000006822
Gene Symbol: LOC103461467
3 Cross references
539 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSPREG00000000044
Gene Symbol: LOC103462326
3 Cross references
474 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSPREG00000002404
Gene Symbol: LOC103476434
2 Cross references
528 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).